Results 191 to 200 of about 287,217 (298)

Disseminated tuberculosis complicating Bacillus Calmette-Guérin (BCG) vaccine as only presentation of severe combined immunodeficiency (SCID): A report of 3 cases. [PDF]

Qatar Med J, 2023
Omer K, Algaly G, Mohamed Salih OA.
europepmc   +1 more source

Transplantation Outcomes for Severe Combined Immunodeficiency 2000–2009

Pediatrics, 2015
T. Fleisher
semanticscholar   +1 more source

Estimation of the prevalence of severe combined immunodeficiency disease in UK Arab horses as determined by a DNA‐based test [PDF]

, 1999
June Swinburne, Lesley Lockhart, M. Scott, M. M. Binns   +3 more
openalex   +1 more source

Two Novel Homozygous Mutations in Phosphoglucomutase 3 Leading to Severe Combined Immunodeficiency, Skeletal Dysplasia, and Malformations

, 2021
Mathieu Fusaro, Aline Vincent, Martin Castelle, Jérémie Rosain, Benjamin Fournier, Maria Veiga‐da‐Cunha, Takfarinas Kentache, Jill Serre, Catherine Fallet‐Bianco, Anne‐Lise Delezoide, Laurent Renesme, Fanny Morice Picard, Eulalie Lasseaux, Nathalie Aladjidi, Nathalie Séta, Valérie Cormier‐Daire, Emile Van Schaftingen, Bénédicte Neven, Despina Moshous, Sophie Blesson, Capucine Pïcard   +20 more
openalex   +2 more sources

Comprehensive Framework for Oncology Pharmacist‐Led Parenteral Anticancer Therapy Patient Education: The Opinion of the American College of Clinical Pharmacy Hematology/Oncology Practice and Research Network

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, EarlyView.
This narrative review summarizes evidence for effective patient education on parenteral anticancer therapies. The authors propose a structured framework for oncology pharmacist‐led patient education on parenteral anticancer therapies that combines pharmacotherapy knowledge and the application of patient‐centered care.
Erin Hickey Zacholski, Jack Dierckes, David Hartnett‐Quach, Cady Noda, Amanda Sharps, Olivia White, Kyle Zacholski, Shawn P. Griffin   +7 more
wiley   +1 more source

Three-year-old with severe-combined immunodeficiency and a mildly expansile T2/FLAIR signal abnormality. [PDF]

Brain Pathol, 2023
Smith VL, Harrison WT.
europepmc   +1 more source

Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency [PDF]

, 2006
José A. M. Borghans, Robbert G. M. Bredius, Mette D. Hazenberg, Helene Roelofs, Els C. Jol‐van der Zijde, J Heidt, Sigrid A. Otto, Taco W. Kuijpers, Willem E. Fibbe, Jaak M. Vossen, Frank Miedema, Maarten J. van Tol   +11 more
openalex   +1 more source

A Phase 1 Study of the Pharmacokinetics, Safety, and Tolerability of Posdinemab (JNJ‐63733657) in Healthy Chinese Adults

The Journal of Clinical Pharmacology, EarlyView.
Abstract Posdinemab, a humanized immunoglobulin G1/κ monoclonal antibody, binds with high affinity to phosphorylated tau protein which is associated with Alzheimer's disease (AD) pathophysiology. Posdinemab reduced tau seeding in murine models and was well tolerated in Phase‐1 clinical studies.
Fangfang Wang, Juanfang Liu, Daisy Bai, Lingjue Li, Maggie Fedgchin, David Henley, Haiyan Li, Fan Zhang   +7 more
wiley   +1 more source

Newborn Screening for Severe Combined Immunodeficiency: Lessons Learned from Screening and Follow-Up of the Preterm Newborn Population. [PDF]

Int J Neonatal Screen, 2023
Gaviglio A, Lasarev M, Sheller R, Singh S, Baker M.   +4 more
europepmc   +1 more source

Introducing Newborn Screening for Severe Combined Immunodeficiency (SCID) in the Dutch Neonatal Screening Program [PDF]

, 2018
Maartje Blom, Robbert G. M. Bredius, Gert Weijman, Eugènie Dekkers, Evelien A. Kemper, M. Elske van den Akker‐van Marle, C.P.B. van der Ploeg, Mirjam van der Burg, Peter C. J. I. Schielen   +8 more
openalex   +1 more source